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a  b  s  t  r  a  c  t
Previous  reports  suggest  that  the  resistance  of  neuronal  cytoskeleton  to drug  toxicity  may
vary  with  age and  gender.  The aim  of  the present  study  was  to assess  the impact  of  cyto-
sine  arabinoside  (AraC)  treatment  on neuroﬁlament  (NF)  levels  and  phosphorylation  status
in the  developing  cerebellum  of  male,  female  and  testosterone  propionate  (1.25  mg/rat)-
androgenized  female  rats. AraC (200  mg/kg  bw)  was  administered  from  postnatal  day  (PND)
14–16 and  changes  in  the  level  and  phosphorylation  of  NFs  were  detected  at  PND  16
by Western  blot  analysis.  The  drug  had  no  effect  in  male  pups,  while  it increased  the
non-phosphorylated  NF subunits  of  medium  and  low  molecular  weight  in  females.  Andro-
genization  of  females  prevented  the  AraC-induced  increase  in  NF  subunits.  The levels  of
estrogen receptor  beta  (ER-),  known  to mediate  neuroprotective  actions  of estrogens  in
the brain,  were  signiﬁcantly  higher  in  the  developing  female  cerebellum,  as  compared  to
males and  androgenized  females.Chemical compounds studied in this article:
Cytosine arabinoside (PubChem CID 6253)
These data  show  that  the  neuroﬁlament  cytoskeleton  in  the  developing  rat  cerebellum
exhibits  resistance  to AraC  that  appears  sexually  dimorphic.  In young  males  the resistance
is  exempliﬁed  by  a lack  of responsiveness,  whereas  in juvenile  females  it is presented  by
an androgenization-sensitive  NF  upregulation.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cytosine arabinoside (AraC) is a cytostatic drug widely
used in the treatment of leukemia. The anticancer property
of  AraC is based on its ability to inhibit DNA replication
and topoisomerase II mediated DNA repair [6,36]. In non-
dividing  cells, like postmitotic neurons, AraC is implicated
in  the generation of reactive oxygen species that trigger
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).DNA strand breaks [12]. The cerebellum is vulnerable
to AraC toxicity and complications affecting its function
are  ranging from transient and mild to permanent ones
[40].  Neuroﬁlaments (NF), the most abundant proteins of
neuronal  cytoskeleton, are essential for the maintenance
of cell structure and organelles’ transport along the axes
[29].  These proteins are common targets of neurotoxic
agents [21,28]. Accumulation of neuroﬁlament aggregates
has  been found in perikarya of postmortem cerebella of
AraC-treated individuals [38], as well as in a number of
neurological disorders including motor neuron disease
and  dementias, suggesting a ﬁlamentous degeneration
process in these disorders [20].
NFs are heteropolymers of three main subunits (NF-H
200  kDa, NF-M 170 kDa, NF-L 68 kDa) whose balance and
phosphorylation state is particularly important for the
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ormation and integrity of the neuronal cytoskeleton.
ajority of axonal NFs is highly phosphorylated and
onstitute a static pool integrated to the axis cytoskeleton,
hile a minor, less phosphorylated, fraction is involved in
xonal  transport [7]. Increased phosphorylation of NF-M
nd  NF-H side arm domains is associated with slower
ransport rates [2]. On the other hand, phosphorylated
Fs are less susceptible to proteolytic degradation [7],
mplying the importance of phosphorylation dynamics in
Fs’  integrity and function.
We have previously shown that AraC administration in
dult  rats leads to a decrease of NFs in the molecular layer of
he  cerebellum that is accompanied by motor deﬁcits [16].
mong  the three NF subunits, NF-H exhibited an increased
usceptibility to AraC treatment [17].
During the ﬁrst two weeks of life in rodents, cere-
ellum is considered more sensitive in AraC toxicity due
o  the increased permeability of the blood brain barrier,
omparing to adult [37]. During this period, the impact
f  AraC administration on this area has been extensively
nvestigated [27,26,32], and severe deﬁcits in glia, neu-
onal  migration and cerebellar cortex formation have been
emonstrated in drug-treated animals. However, there is
aucity  in the literature concerning AraC toxicity at the
eginning of the third postnatal week. At this stage, precur-
ors  of granular cells continue their mitosis in the external
ranular layer (EGL) and migrate through the molecular
one to form the internal granular layer, guided by radial
lia  [14]. The presence of dividing cells in the EGL along
ith  postmitotic but still maturing Purkinje cells, render
he  developing cerebellum a good model for the study of
raC  effects on heterogeneous neuronal populations [1].
e  selected the third postnatal week as a timeframe for
he  examination of AraC impact on cerebellar development
ue to the combination of dividing and non dividing neu-
ons  that occurs during the selected period. These neuronal
opulations would have a distinct response to AraC. The
aturation of Purkinje cells with the development of den-
ritic  synapses also takes place during the third postnatal
eek [25]. In contrast, postpartum human cerebellum his-
ology  already resembles the adult one, with EGL having
lready disappeared. Hence, despite the fact that AraC is
idely  administered during leukemia treatment in young
hildren, there is little direct clinical relevance between the
hird  postnatal week rodent cerebellum and that of a young
uman.
The  aim of the present study was to investigate the effect
f  AraC on the neuroﬁlament component of cytoskeleton in
he  rat cerebellum during the third week of life. Since there
re  studies suggesting that neuroprotection is biased by
he  gender [4], we studied animals of both sexes. Accord-
ng  to the literature, the adult female brain appears more
esistant to toxins owing to the neuroprotective action of
strogens  [4]. Upon neuronal damage, estrogen treatment
as  been shown to attenuate proteolytic degradation of
Fs  [33]. In a rat model of head injury, NF-M in the adult
emale hippocampus was more resistant to degradation
nd a signiﬁcant increase of this subunit was observed dur-
ng  recovery [18]. To elucidate the nature of the observed
ex  differences in response to AraC, we further included
n  the study females that were neonatally androgenizedports 1 (2014) 650–657 651
during the critical period of brain sexual differentiation.
The levels of estrogen receptor beta (ER-) were also
determined as a possible mediator of neuroprotection.
ER- has been implicated in the regulation of cytoskeleton
proteins, including NFs [11,31]. In the developing cerebel-
lum,  ER--mediated actions may  help the growth process
for  which cytoskeletal proteins are indispensable [15].
2.  Materials and methods
2.1.  Animal groups and experimental design
Sixteen day-old Wistar rats were used in this study.
The animals’ genitors were purchased from the Hellenic
Pasteur Institute (Athens, Greece) and acclimated in our
vivarium (lights on from 06:00 to 18:00 h) before breed-
ing,  having free access to food and water. The experimental
design consisted of two  phases.
In Phase I, both male and female rats were used. On
postnatal day (PND) 14, the pups within each litter were
randomly assigned per sex to either the AraC or the Con-
trol  group (6–7 per group). Pups in the AraC group were
s.c.  injected with 200 mg/kg bw of AraC (Aracytin, Pharma-
cia),  a dose capable to penetrate the blood brain barrier and
reach  the brain [26]. In our former experiment in adult rats
[16,17]  we used a higher dose 400 mg/kg bw administered
intraperitoneally, which appeared to cause signiﬁcant sys-
tematic  toxicity during a pilot study we  performed with
developing rats. As a result we  decided to use a lower
dose subcutaneously which proved to penetrate the blood
brain  barrier (as demonstrated by its impact on dividing
cells in the EGL). The suggested human low s.c. dose is
2  × 10 mg/m2/d for a 14-day scheme but at this dose the
drug  is unlikely to cross the blood brain barrier [41]. Con-
trol  pups were injected with normal saline. Injections were
applied  once per day (at 10 am)  from PND 14 to 16 and
adjustment of the drug dose to body weight was  made
when appropriate. Upon injections, the pups were returned
to  their mothers in the home cage. On PND 16, the animals
were decapitated 6 h post injection.
In Phase II, only female pups were used. On PND 3, the
animals were s.c. injected with either sesame oil or testos-
terone propionate (1.25 mg/rat in 50 l of sesame oil), to
induce  brain androgenization [19,34,39]. On PND 14, the
pups  were randomly assigned to either the AraC or the
Control group and treated thereafter as in Phase I.
All  animal treatments were performed according to the
guidelines of the European Communities Council Directive
of  24 November 1986 (86/609/EEC) on the ethical use of
animals  and the experimental protocol was approved by
the  Ethical committee of the School of Medicine, Athens
University.
2.2.  Histology
Nissl staining was applied to examine the effect of AraC
treatment in cerebellum architecture and tissue morphol-
ogy.  Formalin-ﬁxed parafﬁn-embedded cerebella halves
from  Phase I experiment were used. Six micrometer thick
midline  sagittal sections were collected onto silane-coated
slides. Upon deparafﬁnation and rehydration the sections
ology Re652 C. Koros, E. Kitraki / Toxic
were stained overnight in a solution containing 1% tolu-
idine  blue. Intense staining was partly removed using
successive alcohol solutions 50% and 70%. The external
granular layer (EGL) width was measured in lobules IV–VI
using  the Image Pro Plus software (Media Cybernetics). Five
different  optic ﬁelds from each tissue block were measured
(10  measurements of the width in regular intervals for each
optic  ﬁeld) under the 20× objective magniﬁcation, by two
independent observers, blindly. The difference between
the  two scorers was always lower than the standard error
of  the measurements.
2.3.  Western blot analysis
Western  blot analysis was used to determine the
levels of non-phosphorylated and phosphorylated NF sub-
units,  as well as the levels of estrogen receptor beta
(ER-). At sacriﬁce, cerebella were immediately frozen in
liquid  nitrogen and stored in –80 ◦C until use. The tis-
sue was homogenized by sonication in ice cold buffer
(100 mM  Tris–HCl pH 7.6, 150 mM NaCl, 0.5 mM DTT, 0.1%
SDS  and 1 mM PMSF) and centrifuged at 14,000 rpm for
20  min  at 4 ◦C. The supernatants were used for Western
blot analysis, as previously described [17]. The following
primary antibodies were applied overnight at 4 ◦C: a mono-
clonal  antibody against a common epitope of the three
subtypes of non-phosphorylated neuroﬁlaments (1:500,
Dako  A/S, Denmark), a monoclonal antibody against the
phosphorylated subunits pNF-H and pNF-M (1:1000, Mil-
lipore  Corporate, Billerica, MA,  USA), a polyclonal antibody
against estrogen receptor beta (B1N1, 1:1000, kindly pro-
vided  by Dr. M.N. Alexis, [5]) and a monoclonal antibody
against b-actin (1:10,000, Chemicon International Inc.,
Temecula, CA, USA). Appropriate biotinylated secondary
antibodies were used and the immunoreactivity signal was
visualized  by the use of 3,3-diaminobenzidine tetrahy-
drochloride (Dako A/S, Denmark).
For quantiﬁcation of the signal, the membranes were
scanned and the optical density (OD) of each band was
divided by the respective b-actin band OD reading, to cor-
rect  for protein loading. A ﬁxed square frame was used to
capture  each protein band and after the background sig-
nal  was subtracted by selecting a background area of the
membrane, the OD of each band was calculated from pixel
density  using Image Pro Plus software. Each sample was
run  three times in order to obtain reliable density data. To
normalize the measurements among different membranes,
the  same control sample was included in all membranes.
2.4. Statistics
Two-way analysis of variance (ANOVA), with AraC treat-
ment  and sex (Phase I) or AraC treatment and testosterone
treatment (Phase II) as the independent factors, followed by
the  Bonferroni post hoc test when appropriate, was used to
evaluate  signiﬁcant effects on EGL width, and on the levels
of  pNF-H, pNF-M and ER-. Furthermore, the effect of AraC
and  sex (or testosterone treatment) on the three neuroﬁla-
ment subunits was analyzed by repeated two-way ANOVAports 1 (2014) 650–657
with  subunit as the within-subject factor. Signiﬁcance was
set  at p < 0.05.
3. Results
3.1. Effects of AraC in the cerebellum of male and female
pups
3.1.1. Histological observations
A  signiﬁcant effect of AraC was evidenced on the
width of the external granular layer (F(1,23) = 45.285,
p < 0.001) (Fig. 1e). Sixteen-day old AraC-treated male and
female  rats had decreased to undetected EGL width, com-
pared  to the control groups [(F(1,10) = 19.205, p = 0.002 and
(F(1,12) = 27.569, p < 0.0001) for males and females, respec-
tively].
Abundant spindle-shaped granular cells migrating from
the  external to the internal granular layer were detected
within the molecular layer in the control groups (Fig. 1a
and  c). These cells were scarcely observed or even absent
in  some lobules of AraC-treated animals (Fig. 1b and d).
AraC  treatment did not signiﬁcantly affect the formation of
Purkinje  and internal granular cerebellar layers.
3.1.2. Effect on NF subunits and phosphorylation
AraC treatment differentially affected NF subunits in the
cerebellum of 16-day old male and female rats (Fig. 2a
and  b). More speciﬁcally, repeated two-way ANOVA for
the  three subunits revealed a signiﬁcant effect of sub-
unit  (F(2,44) = 7.953, p = 0.001), as well as a signiﬁcant
subunit × AraC interaction (F(2,44) = 4.643, p = 0.015). When
analyzed per sex, the effect of AraC was  statistically sig-
niﬁcant in females (F(1,10) = 6.032, p = 0.034), but not in
males. An interaction of sex × AraC was also signiﬁcant
(F(1,22) = 4.727, p = 0.041). Post hoc analysis for each sub-
unit showed an increase of NF-M levels in the female
AraC group, compared to control females (p = 0.015) and to
AraC  males (p = 0.039). Increased levels of NF-L were also
detected in female AraC group compared to both female
control and male AraC groups (p = 0.011 and p = 0.006,
respectively). No signiﬁcant changes were observed for the
NF-H  subunit. No effect of sex, AraC treatment or their
interaction was  detected in the levels of phosphorylated
subunits (Fig. 2c).
3.1.3.  Effect on ER-  ˇ levels
The  levels of ER- in the female cerebellum were higher
than in male, irrespective of AraC treatment (Fig. 2d and
e).  More speciﬁcally, a signiﬁcant effect of sex on the lev-
els  of ER- was evidenced in our study (F(1,19) = 37.628,
p < 0.001). Subsequent analysis showed increased ER- lev-
els  in control females comparing to males (p = 0.002) and in
AraC-treated females comparing to their male counterparts
(p  = 0.003).
3.2. Impact of perinatal androgenization on AraC effectIn  Phase II experiment we  investigated the possi-
ble impact of early androgenization of female pups on
AraC-induced alterations in NFs and ER- expression. The
success  of testosterone masculinization was veriﬁed by
C. Koros, E. Kitraki / Toxicology Reports 1 (2014) 650–657 653
Fig. 1. (a–d) Representative bright ﬁeld photomicrographs of Nissl stained cerebellum sections from control (a, c) and AraC treated (b, d) male rats.
A  prominent decrease in EGL width could be witnessed in the AraC treated animal comparing to the control. The black frame in (a) [10× objective
m magniﬁ

















dagniﬁcation] corresponds to the area magniﬁed in (c) [20× objective 
agniﬁed  in (d). Black arrow in (a) indicates EGL location and white arrow
n  EGL width in the developing cerebellum of male and female rats. Bars 
easurements of the urogenital distance of pups at sac-
iﬁce.  The mean distance was 1.01 ± 0.04 cm in males,
.59 ± 0.02 cm in intact females and 0.77 ± 0.04 cm in
estosterone-treated females.
.2.1. Impact on neuroﬁlament alterations
Early androgenization prevented the AraC-induced
ncreases in NF that were observed in 16-day old female
ups  (Fig. 3a and b). Statistical analysis showed that AraC
reatment had an initial signiﬁcant effect (F(1,20) = 6.624,
 = 0.018) on each neuroﬁlament subunit. Subsequent per
ubunit  analysis showed an increase of NF-M levels in AraC-
reated  females, compared to control females (p = 0.025).
owever, AraC-treated androgenized females did not dif-er  from their control counterparts. NF-L levels were also
igher  in the AraC females, as compared to the controls
p  = 0.010), whereas those of testosterone-treated group
id  not differ. No signiﬁcant changes were observed for thecation] and accordingly the black frame in (b) corresponds to the area
dicates migrating granular cells, respectively. (e) Effect of AraC treatment
nt mean ± SEM of EGL width. Signiﬁcance was set for p < 0.05.
NF-H  subunit. Androgenization had no effect on the impact
of  AraC in the status of NF subunit phosphorylation (Fig. 3c).
3.2.2.  Impact on ER-  ˇ levels
Perinatal  androgenization reduced ER- levels in
testosterone-treated females, irrespective of AraC treat-
ment  (Fig. 3d and e). Statistical analysis revealed an
overall signiﬁcant effect of testosterone treatment on the
levels  of ER- (F(1,19) = 11.484, p = 0.004). Subsequent anal-
ysis showed reduced ER- levels in testosterone-treated
females, compared to their non-androgenized female
counterparts (p = 0.039 for controls and p = 0.048 for AraC-
treated  pups).
4.  DiscussionThe main ﬁnding of this study is that the NF component
of the cytoskeleton in the cerebellum of 16-day old rats
exhibits resistance to AraC in a sexually dimorphic pattern.
In  contrast to the reported AraC-induced reduction of NFs
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Fig. 2. Effect of AraC on NFs and ER- of male and female rats. (a) Effect of AraC on the levels of non-phosphorylated neuroﬁlament subunits (NF-H,
NF-M,  NF-L) in the developing cerebellum of male and female rats. Bars represent mean ± SEM of OD ratio of each NF subunit/actin band in each sample.
(b)  Representative Western immunoblot for the NF subunits in experimental groups. (c) Effect of AraC on the levels of phosphorylated subunits (pNF-H,
pNF-M)  in the developing cerebellum of male and female rats. Bars represent mean ± SEM of OD ratio of each pNF subunit/actin band in each sample. (d)
Effect  of AraC on the levels of estrogen receptor beta (ER-) in the developing cerebellum of male and female rats. Bars represent mean ± SEM of OD ratio
of  ER-/actin band in each sample. (e) Representative Western immunoblot for ER- in experimental groups. Signiﬁcance was set for p < 0.05.
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Fig. 3. Effect of AraC on NFs and ER- of female and androgenized female rats. (a) Effect of AraC on the levels of non-phosphorylated neuroﬁlament
subunits (NF-H, NF-M, NF-L) in the developing cerebellum of female and androgenized female rats. Bars represent mean ± SEM of OD ratio of each NF
subunit/actin  band in each sample. (b) Representative Western immunoblot for the NF subunits in experimental groups. (c) Effect of AraC on the levels of
phosphorylated  subunits (pNF-H, pNF-M) in the developing cerebellum of female and androgenized female rats. Bars represent mean ± SEM of OD ratio of
each  pNF subunit/actin band in each sample. (d) Effect of AraC on the levels of estrogen receptor beta (ER-) in the developing cerebellum of female and
androgenized  female rats. Bars represent mean ± SEM of OD ratio of ER-/actin band in each sample. (e) Representative western immunoblot for ER- in
experimental  groups. Signiﬁcance was set for p < 0.05.
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in the cerebellum of adult rats [17,16], toxin administra-
tion in the beginning of the third week of life had either no
effect  on NF levels (in males) and phosphorylation status
(in  both sexes) or even increased two of the NF subunits (in
females).  In the adult cerebellum, reduced NF levels and in
particular  NF-H form following AraC is considered as a hall-
mark  of degeneration and is accompanied by motor deﬁcits
[16].  At this point we should highlight the fact that a direct
comparison between adult and neonatal rats is problem-
atic because the dose and exposure time to AraC differed.
Moreover, data concerning the impact of AraC on female
adult  rats are missing.
The  lack of changes in the levels of NF proteins in the
immature male rat cerebellum is indicative of an increased
resistance to AraC toxicity. Interestingly, in female pups
AraC  treatment increased the levels of NF-M and NF-
L  subunits. The mechanism and the importance of this
upregulation are not clear but it may  represent a reac-
tive  compensatory mechanism to lesion, favoring local
tissue  reorganization in the female cerebellum. It is worth
noting  that NF-M is considered to be a main regulator
of radial axonal growth [9] and is the preferred sub-
unit for NF-L co-polymerization. Additionally, a common
regulation of these two forms (NF-M and NF-L) is antic-
ipated, as their genes reside in the same chromosome
[24].
To assess whether the observed sexually dimorphic
responses to AraC could be attributed to the female back-
ground, we exposed female pups to androgens during the
critical  period of brain sexual differentiation, a manipula-
tion known to masculinize developing neural circuits [23].
Our  data veriﬁed that the observed increases in NF-M and
NF-L  are dependent on an intact female brain program-
ing.
We  hypothesized that the different levels of ER- recep-
tor  between the two sexes may  interfere with the sexually
dimorphic outcome of AraC on neuroﬁlaments in the
developing cerebellum. We  did detect that ER- levels in
female  pups were ﬁve-fold higher compared to their male
counterparts and that they were signiﬁcantly reduced in
androgenized females. These ﬁndings suggest that ER-
could  be involved in the sexually dimorphic alterations
of NF levels induced by AraC. However, apart from ER-
,  additional mediators are probably participating in this
female-speciﬁc increase of NF subunits following AraC and
further  studies are required to clarify the underlying mech-
anism.
The  observation of this study that cerebellar NFs are
less  susceptible to neurotoxins during development is
supported by previous ﬁndings in the rat hippocampus.
Lopez-Picon et al. [22] showed that NF subunits in the
hippocampus of adult, but not immature rats are vulner-
able  to degradation following kainic acid administration.
In the same study, all three non-phosphorylated NF sub-
units  underwent a substantial increase in the hippocampus
of 9-day old kainic acid-treated pups (not separated by
sex)  that was  normalized one day later. This observa-
tion is quite similar with the ﬁnding of the present study
and  implies the existence of common cellular responses
of  cytoskeleton components to neurotoxic insults during
development.ports 1 (2014) 650–657
Phosphorylated NFs are less susceptible to prote-
olytic degradation [13] and conversely dephosphorylation
might represent an early step of the loss of NF integrity.
Accordingly, the observed absence of dephoshorylation
following AraC in our study implies that the neuronal
cytoskeleton at this age may  be more resistant to AraC-
induced degradation. In support of this, we  could detect
a  signiﬁcant downregulation of phosphorylated NF-H in
AraC-treated adult rats (Koros and Kitraki, unpublished
data), that coincides with the enhanced vulnerability of
this  subunit to degradation in adulthood [17]. Notably, this
developmental resistance of NFs to changes in the phos-
phorylation status was observed in both sexes, suggesting
that AraC in immature rats does not affect neuroﬁl-
aments’ stability, but rather the cytoskeleton reactive
response to insult that is sexually dimorphic. In agree-
ment with our observations, Lopez-Picon et al. [22], did
not  detect alterations in the phosphorylation of NF-H in
the  developing hippocampus following kainic acid admin-
istration.
At  this point it should be noted that despite the lack
of  alterations in NF phosphorylation status following AraC,
the  rat cerebellum remains vulnerable to AraC toxicity dur-
ing  the third postnatal week. Our data showed that AraC
administration in the beginning of the third week signif-
icantly reduced the width of external granule layer that
comprises of dividing precursors of granular cells. This
is  in accordance with previous studies using other toxic
agents, like phenytoin and cisplatin during the same devel-
opmental period [10,30]. It has been suggested that this EGL
reduction  could impair normal migration of precursor cells
to  form the internal granular layer [3]. Disorganization of
the  guiding radial glia could also add to this normal growth
aberration, as it has been the case for other neurotoxins as
well  [8,35]. Despite the fact that EGL width reduction is not
directly  relevant to NF expression alterations, we  used it as
a  marker of AraC toxicity in the developing cerebellum in
order  to prove accumulation and toxic action of the drug in
the  cerebellum.
5.  Conclusions
Our data support the option that the developmental
stage and the gender can inﬂuence the resistance of neu-
ronal  cytoskeleton to toxic agents. Neuroﬁlaments appear
more  resistant to AraC treatment in young male rats com-
paring  to the effects reported in male adults although the
dose  and exposure time differed. In young females, an
androgenization-sensitive reactive upregulation of NF-M
and  NF-L subunits was observed in the cerebellum follow-
ing  AraC that could implicate ER- participation.
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